about
Non-stationarity in the "resting brain's" modular architecture.Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's diseaseUntreated type 2 diabetes and its complications are associated with subcortical infarctionsInvestigation of 15 of the top candidate genes for late-onset Alzheimer's diseaseCharacterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadicsExpanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentArgyrophilic grains: a distinct disease or an additive pathology?Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed casesThe neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersSuspected non-Alzheimer disease pathophysiology--concept and controversyMild Neurocognitive Disorder: An Old Wine in a New BottleImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plansAt the interface of sensory and motor dysfunctions and Alzheimer's disease.Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.Rarity of the Alzheimer disease-protective APP A673T variant in the United StatesNeuropathologic features of amnestic mild cognitive impairmentAssociation and heterogeneity at the GAPDH locus in Alzheimer's diseaseNovel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosisAdvancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitCreating a transatlantic research enterprise for preventing Alzheimer's diseaseCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseEngaging in cognitive activities, aging, and mild cognitive impairment: a population-based studyAmyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy.Revision of the criteria for Alzheimer’s disease: A symposium.Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyAlzheimer's disease diagnosis in individual subjects using structural MR images: validation studies3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.Singing paraplegia: a distinctive manifestation of a spinal dural arteriovenous fistula.Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration.Age and education corrected older adult normative data for a short form version of the Financial Capacity Instrument.Mayo's Older African Americans Normative Studies: normative data for commonly used clinical neuropsychological measures.A brief report on WAIS-R normative data collection in Mayo's Older African Americans Normative Studies.The Alzheimer's disease neuroimaging initiative.
P50
Q21134508-6AC80700-AFCD-453C-BED8-9C81C2C91309Q24610759-2A3EDE03-8AC4-4A7D-A72B-8E82E4E71448Q24626249-5937FB12-A8EB-46E8-8AEC-C20121387880Q24628049-DA6FDCD3-386C-4ADC-ABCA-1EC14100D457Q24630288-112DBD16-30AE-4E94-8CCE-067FADD7CE9DQ24630362-C5A4D1AD-760A-4C4A-9A9F-35FABE603E55Q24633692-7717623D-0AC2-4FEA-9AA9-E3DB92935E49Q24648319-280C9B83-DFB9-4C5A-BE9F-B120B568E763Q24650928-EAA3AE43-79AA-4875-A7D9-6A578934094AQ24653609-A2F938F7-5745-4B32-9E97-A88A176CE45AQ24656574-35AFA8A9-A042-4132-9725-79261B385D8EQ26745508-1B79B6F3-C39D-46C4-A259-D333ABB7C0EAQ26771270-91BAD94E-9E36-448F-B8E7-0FB49F089978Q26786539-B864C427-57FD-42B3-B929-DBFD841B8C83Q26801629-4204A0A6-E13F-4EE8-AAAC-608A3217877CQ26801657-476D6276-721C-4C6F-A4DA-3F8563B480FAQ27000410-DA0738B2-61BA-48A6-853B-44F5A2A6A8F6Q27310276-30C8ED12-964E-4D81-895E-47D960297B6CQ27346292-7B6BE76D-B64E-4A8D-9A0C-EDD385A7D5B0Q28238965-59705DAC-F888-4ECD-B6C1-A4E07E6C6F23Q28294024-0BE53F8F-14FE-4A47-99C8-395DDCC5DDE3Q28473603-B1620BE4-2751-4173-9878-DC75CEAD6C13Q28709591-4C9397A7-CA03-4DE4-8058-3A9B4E3B6753Q28731473-32661574-76C2-4D1F-97FA-29ECEA6FDB64Q28943325-4BBCBD79-2BEF-48C9-8B1A-C4AFE206704BQ29614406-6D18CAB9-7017-44D5-B333-B8B301F4BAD5Q30403907-FF8E3156-9633-4D23-B9F3-19F6E7D8D929Q30452604-F8F3B330-F8B8-4B5B-BDD9-F9BA23859A40Q30452902-287371BC-C490-40AD-8611-38D463DD9C47Q30459046-B363679D-A85C-41BE-97F8-407754EB5A96Q30481978-1CAF7EA0-A295-467A-87B3-CB9EE3CF63D9Q30496583-CF3E5D85-973B-4EDE-8F9B-5081C104F28EQ30540048-E4C3582D-C8C0-470C-A027-DE8940EA8E5DQ30592862-4B07F32C-8A84-4D4E-BDB5-B5E2A90F212DQ30971403-3034806E-8A3F-43AD-BE4D-AF3A8A7B9DB0Q30978387-12B64DD3-6A36-4236-9033-192D04D98B9AQ30979989-465614B1-CF87-4A72-88EA-77A81CE63332Q30994434-D14A6C62-6F98-4302-9AFE-DCFCFA57A35CQ30994439-CE586C51-B4D8-4BB6-B4D1-FB224F798511Q31030939-AF5AF934-6A21-4156-ACC0-007D2C832322
P50
description
neurologist
@en
neuroloog
@nl
name
Ronald C. Petersen
@ast
Ronald C. Petersen
@en
Ronald C. Petersen
@es
Ronald C. Petersen
@nl
type
label
Ronald C. Petersen
@ast
Ronald C. Petersen
@en
Ronald C. Petersen
@es
Ronald C. Petersen
@nl
altLabel
Ronald Carl Petersen
@en
prefLabel
Ronald C. Petersen
@ast
Ronald C. Petersen
@en
Ronald C. Petersen
@es
Ronald C. Petersen
@nl
P166
P1006
P214
P244
P1006
P106
P1153
57193645972
P166
P21
P214
P244
P31
P569
1946-05-24T00:00:00Z
P691
mub2015883290
P734
P735
P7859
lccn-n89225319